James Patrick Kelly Net Worth & Insider Trades

James Patrick Kelly - EVP & Chief Financial Officer, Vanda Pharmaceuticals Inc

As of January 4, 2018

What is James Patrick Kelly's Net Worth?

The current estimated net worth of Vanda Pharmaceuticals Inc's EVP & Chief Financial Officer, James Patrick Kelly, is estimated to be about $2.98M . James Patrick Kelly owns about 168,066 units of Vanda Pharmaceuticals Inc common stock. In the last 7 years at Vanda Pharmaceuticals Inc, James Patrick Kelly has sold an estimated value of $713.17K worth.

What is James Patrick Kelly's Past Insider Trading?

James Patrick Kelly's largest purchase order was 5,000 units , worth over $29.95K on August 30, 2011. James Patrick Kelly's largest sale order was 10,895 units , worth over $169.01K on January 5, 2017. In total, James Patrick Kelly has made about 16 transactions over 7 years of their time at Vanda Pharmaceuticals Inc. James Patrick Kelly usually trades in December and February, with the busiest year in 2013. The most recent transaction was a sale order of 9,155 units , worth over $140.49K on January 4, 2018.

James P. Kelly

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was James Patrick Kelly's Salary in 2020?

As EVP & Chief Financial Officer of Vanda Pharmaceuticals Inc, James Patrick Kelly has a total base salary of $124,057 . James Patrick Kelly received compensation valued at about $140,274 in 2020 after becoming EVP & Chief Financial Officer. The vast majority of their compensation came in the form of other compensation of $16,217 .

What is James Patrick Kelly's' Mailing Address?

  • Mailing address is C/o Supernus Pharmaceuticals, Inc. 9715 Key West Avenue Rockville MD 20850 MD

Vanda Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Mihael H. Polymeropoulos, M.D. 2020 $746,235 - $679,200 $795,830 $656,687 $35,468 $2,913,420
Mihael H. Polymeropoulos, M.D. 2019 $721,000 - $1,237,200 $1,610,154 $675,000 $34,783 $4,278,137
Mihael H. Polymeropoulos, M.D. 2018 $700,000 - $1,131,000 $1,456,406 $700,000 $37,322 $4,024,728
James P. Kelly 2020 $124,057 - - - - $16,217 $140,274
James P. Kelly 2019 $493,370 - $618,600 $805,077 $288,622 $42,741 $2,248,410
James P. Kelly 2018 $479,000 - $754,000 $832,232 $299,375 $36,778 $2,401,385
Kevin Moran 2020 $324,693 - $331,101 $427,779 $200,000 $36,126 $1,319,699
Joakim Wijkstrom 2020 $506,422 - $339,600 $397,915 $250,679 $29,269 $1,523,885
Aranthan "AJ" Jones II 2020 $406,104 - $339,600 $397,915 $201,021 $33,677 $1,378,317
Timothy Williams 2020 $400,000 - $339,600 $397,915 $200,000 $41,546 $1,379,061
Timothy Williams 2019 $379,315 - $618,600 $805,077 $177,520 $42,342 $2,022,854
Timothy Williams 2018 $144,886 $40,000 $643,500 $1,086,894 $71,918 $15,658 $2,002,856
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1347178/000134717821000008/vnda-20210422xdef14a.htm

What are Vanda Pharmaceuticals Inc's Past Insider Trades?

Vanda Pharmaceuticals Inc's most recent insider trade came on December 16, 2022 by Timothy Williams who sold 8,000 units worth $56.07K . In the last 16 years, insiders at Vanda Pharmaceuticals Inc have sold an estimated value of $297.21M and bought an estimated value of $28.74M worth of shares. Insider trading is most common in June, with the busiest year in 2006. The most active traders at the company are Mihael Polymeropoulos, President and CEO,  James P. Kelly, EVP & Chief Financial Officer,  and Richard W Dugan, Director .

Vanda Pharmaceuticals Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1